Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Sudden death after 125I brachytherapy in prostate cancer patient: a case report].
Kimura M, Satoh T, Fujita T, Okusa H, Matsumoto K, Iwamura M, Kitano M, Ishiyama H, Hayakawa K, Okayasu I, Baba S. Kimura M, et al. Among authors: hayakawa k. Nihon Hinyokika Gakkai Zasshi. 2005 Jul;96(5):560-3. doi: 10.5980/jpnjurol1989.96.560. Nihon Hinyokika Gakkai Zasshi. 2005. PMID: 16083034 Free article. Japanese.
Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, Okusa H, Tabata K, Baba S, Hayakawa K. Ishiyama H, et al. Among authors: hayakawa k. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):23-8. doi: 10.1016/j.ijrobp.2008.11.006. Epub 2009 Feb 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19243900
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Tsumura H, Satoh T, Ishiyama H, Tabata K, Kotani S, Minamida S, Kimura M, Fujita T, Matsumoto K, Kitano M, Hayakawa K, Baba S. Tsumura H, et al. Among authors: hayakawa k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e385-92. doi: 10.1016/j.ijrobp.2011.04.026. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21664068 Clinical Trial.
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up.
Ishiyama H, Satoh T, Kitano M, Tabata K, Komori S, Ikeda M, Soda I, Kurosaka S, Sekiguchi A, Kimura M, Kawakami S, Iwamura M, Hayakawa K. Ishiyama H, et al. Among authors: hayakawa k. J Radiat Res. 2014 May;55(3):509-17. doi: 10.1093/jrr/rrt128. Epub 2013 Nov 11. J Radiat Res. 2014. PMID: 24222312 Free PMC article. Clinical Trial.
A prospective quasi-randomized comparison of intraoperatively built custom-linked seeds versus loose seeds for prostate brachytherapy.
Ishiyama H, Satoh T, Kawakami S, Tsumura H, Komori S, Tabata K, Sekiguchi A, Takahashi R, Soda I, Takenaka K, Iwamura M, Hayakawa K. Ishiyama H, et al. Among authors: hayakawa k. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):134-9. doi: 10.1016/j.ijrobp.2014.05.009. Epub 2014 Jun 28. Int J Radiat Oncol Biol Phys. 2014. PMID: 24986744 Clinical Trial.
2,156 results